Credit Suisse Downgrades Omnicare (OCR) to Neutral
Tweet Send to a FriendGet Alerts OCR Hot Sheet
Price: $47.50 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 20
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 16 | New: 20
Trade OCR Now!
Credit Suisse downgrades Omnicare (NYSE: OCR) from Outperform to Neutral. PT lowered from $33 to $29.
To see all the upgrades/downgrades on shares of OCR, visit our Analyst Ratings page.
Omnicare, Inc. (Omnicare) is a pharmaceutical services company.
To see all the upgrades/downgrades on shares of OCR, visit our Analyst Ratings page.
Omnicare, Inc. (Omnicare) is a pharmaceutical services company.
You May Also Be Interested In
- UPDATE: Bernstein Cuts BlackBerry (BBRY) to Underperform; Notes Weak BB10 Traction
- UPDATE: BofA/Merrill Lynch Downgrades Cliffs Natural Resources (CLF) to Underperform
- Brean Capital Downgrades Tetra Tech (TTEK) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Credit Suisse
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
